Clover Health Investments, Corp.
CLOV· Nasdaq
Released Nov 6, 2023, after the close
10-Q filed Nov 6, 2023, 37 days after period end · 0001801170-23-000104
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $306.03M | $856.82M | $427.16M | $169.07M |
| Net Income | -$41.47M | -$75.49M | -$34.53M | $12.76M |
| EPS Diluted |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.16 |
| -$0.08 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.